Melatonin promotes cardiomyocyte proliferation and heart repair in mice with myocardial infarction via miR-143-3p/Yap/Ctnnd1 signaling pathway
Wen-ya Ma,Rui-jie Song,Bin-bin Xu,Yan Xu,Xiu-xiu Wang,Hong-yue Sun,Shuai-nan Li,Shen-zhen Liu,Mei-xi Yu,Fan Yang,Dan-yu Ye,Rui Gong,Zhen-bo Han,Ying Yu,Djibril Bamba,Ning Wang,Zhen-wei Pan,Ben-zhi Cai
DOI: https://doi.org/10.1038/s41401-020-0495-2
IF: 7.169
2020-08-24
Acta Pharmacologica Sinica
Abstract:The neonatal heart possesses the ability to proliferate and the capacity to regenerate after injury; however, the mechanisms underlying these processes are not fully understood. Melatonin has been shown to protect the heart against myocardial injury through mitigating oxidative stress, reducing apoptosis, inhibiting mitochondrial fission, etc. In this study, we investigated whether melatonin regulated cardiomyocyte proliferation and promoted cardiac repair in mice with myocardial infarction (MI), which was induced by ligation of the left anterior descending coronary artery. We showed that melatonin administration significantly improved the cardiac functions accompanied by markedly enhanced cardiomyocyte proliferation in MI mice. In neonatal mouse cardiomyocytes, treatment with melatonin (1 μM) greatly suppressed miR-143-3p levels. Silencing of miR-143-3p stimulated cardiomyocytes to re-enter the cell cycle. On the contrary, overexpression of miR-143-3p inhibited the mitosis of cardiomyocytes and abrogated cardiomyocyte mitosis induced by exposure to melatonin. Moreover, Yap and Ctnnd1 were identified as the target genes of miR-143-3p. In cardiomyocytes, inhibition of miR-143-3p increased the protein expression of Yap and Ctnnd1. Melatonin treatment also enhanced Yap and Ctnnd1 protein levels. Furthermore, Yap siRNA and Ctnnd1 siRNA attenuated melatonin-induced cell cycle re-entry of cardiomyocytes. We showed that the effect of melatonin on cardiomyocyte proliferation and cardiac regeneration was impeded by the melatonin receptor inhibitor luzindole. Silencing miR-143-3p abrogated the inhibition of luzindole on cardiomyocyte proliferation. In addition, both MT1 and MT2 siRNA could cancel the beneficial effects of melatonin on cardiomyocyte proliferation. Collectively, the results suggest that melatonin induces cardiomyocyte proliferation and heart regeneration after MI by regulating the miR-143-3p/Yap/Ctnnd1 signaling pathway, providing a new therapeutic strategy for cardiac regeneration.
pharmacology & pharmacy,chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper aims to explore whether melatonin can promote cardiomyocyte proliferation and cardiac repair by regulating the miR-143-3p/Yap/Ctnnd1 signaling pathway, and to investigate its mechanism of action in a mouse model of myocardial infarction (MI).
Specifically, the paper addresses the following issues:
1. **The effect of melatonin on cardiomyocyte proliferation**: Investigated whether melatonin can promote the proliferation of neonatal mouse cardiomyocytes.
2. **Melatonin's cardiac repair ability**: Explored whether melatonin can improve cardiac function after myocardial infarction by promoting cardiomyocyte proliferation.
3. **The mechanism of miR-143-3p**: Studied the role of miR-143-3p in melatonin-induced cardiomyocyte proliferation and its relationship with Yap and Ctnnd1.
4. **Dependence on melatonin receptors**: Investigated whether the effects of melatonin on cardiomyocyte proliferation and cardiac repair depend on the activation of melatonin receptors.
Through these studies, the paper reveals a new mechanism by which melatonin promotes cardiomyocyte proliferation and cardiac repair by regulating the miR-143-3p/Yap/Ctnnd1 signaling pathway, providing new strategies for the treatment of cardiovascular diseases.